Your browser doesn't support javascript.
loading
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Oaknin, Ana; Monk, Bradley J; Vergote, Ignace; Cristina de Melo, Andreia; Kim, Yong-Man; Lisyanskaya, Alla S; Samouëlian, Vanessa; Kim, Hee Seung; Gotovkin, Evgeniy A; Damian, Fernanda; Chang, Chih-Long; Takahashi, Shunji; Li, Jingjin; Mathias, Melissa; Fury, Matthew G; Ivanescu, Cristina; Reaney, Matthew; LaFontaine, Patrick R; Lowy, Israel; Harnett, James; Chen, Chieh-I; Tewari, Krishnansu S.
Affiliation
  • Oaknin A; Gynaecologic Cancer Programme, Vall D'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: aoaknin@vhio.net.
  • Monk BJ; Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ, USA.
  • Vergote I; Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University Hospitals, KU Leuven, Leuven, Belgium.
  • Cristina de Melo A; Division of Clinical Research and Technological Development, Hospital Do Câncer II, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • Kim YM; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Lisyanskaya AS; St Petersburg State Budgetary Institution of Healthcare, St Petersburg, Russia.
  • Samouëlian V; Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Centre Hospitalier de L'Université de Montréal (CHUM), Centre de Recherche Du Centre Hospitalier de L'Université de Montréal (CRCHUM) and Université de Montréal, Montreal, Canada.
  • Kim HS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.
  • Gotovkin EA; State Budget Healthcare Institution Ivanovo Regional Oncology Dispensary, Ivanovo, Russia.
  • Damian F; Centro de Pesquisa Em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, Brazil.
  • Chang CL; Department of Obstetrics and Gynecology, Mackay Memorial Hospital and Department of Medicine, Mackay Medical College, Taipei, Taiwan.
  • Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Li J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Mathias M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Ivanescu C; IQVIA, Amsterdam, Netherlands.
  • Reaney M; IQVIA, London, UK.
  • LaFontaine PR; Sanofi, Cambridge, MA, USA.
  • Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Harnett J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Chen CI; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Tewari KS; Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of California, Irvine, CA, USA.
Eur J Cancer ; 174: 299-309, 2022 10.
Article in En | MEDLINE | ID: mdl-35922251
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Uterine Cervical Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Uterine Cervical Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article